Market by Source, Product, Application, and Country Outlook | Forecast 2022-2028
Triton’s research report
estimates that the medical collagen market in the Asia-Pacific region is set to
register revenue growth at a compound
annual growth rate of 7.23% during the forecast period 2022-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries scrutinized in the given region include:
•
China
•
Japan
•
India
•
South Korea
•
ASEAN Countries
•
Australia & New Zealand
•
Rest of Asia-Pacific
In
Asia-Pacific, China holds the majority of shares in the medical collagen
market. The region’s
growth is mainly owing to the high adoption of collagen products. Moreover, the
beauty industry has developed significantly over the past years, resulting in
high demand for collagen-based products and treatments. Furthermore, the
consumers are incorporating collagen products into their diets, such as
capsules and supplements. The significant investments in R&D activities
also surged the demand for collagen. Therefore, all these factors are expected
to create numerous opportunities for the medical collagen market across the
region.
In China, consumers are opting for collagen
supplements for beauty and bone-related purposes. Presently, peptides and
marine collagen in the powdered form are in high demand across the country.
This has encouraged various prominent companies to expand their product
portfolio, leading to new launches. For instance, Nestle Health Science
established a flagship store for collagen products. Another company called the
New Age Company launched its Noni+collagen product. The protein-rich collagen
products are gaining popularity in the country, thereby influencing the growth
of the medical collagen market across China.
Japan has witnessed a substantial rise in demand
for collagen products, including face cream, shampoo, and tablets. Several
domestic companies like Asahi Perfect and Fancl HTC are leading the studied
market in the country. This rise in local companies is anticipated to support
the medical collagen market’s growth over the forecast period.
Hydrolyzed collagen is formed by breaking down
protein into small parts for easy and quick digestion. This process is referred
to as hydrolysis. Moreover, this collagen is highly beneficial in treating
conditions related to skin, joint, muscle, heart, and hair, among others. In
this regard, it helps build muscle and strengthens the joints. The given market’s growth is assessed based
on product, source, and application. The product segment is divided into
hydrolyzed collagen, gelatine, native collagen, and other products.
The
leading companies in the medical collagen market consist of Nitta Gelatin Inc,
Darling Ingredients Inc, Collagen Matrix Inc, Stryker, Integra Life Sciences,
and DSM.
Nitta Gelatin is a leading company offering gelatin and collagen-related products to consumers. The company serves clients across multiple sectors, including food, dietary supplement, and pharmaceutical. Its product line includes CapsiGuard DRG gelatin, designed to restrict cross-linkage reactions. The company has operations across multiple regions. Founded in 1979, Nitta Gelatin is headquartered in Osaka, Japan. The company witnessed significant revenue growth in 2021.
Key deliverables of the report:
●
Market CAGR during the forecasting years 2022-2028
●
Detailed data highlighting key insights, industry components, and
market strategies
● Comprehensive information and estimation of the medical collagen
market revenue growth in the Asia-Pacific and its influence on the parent
market
●
In-depth study of forthcoming trends in consumer behavioral
patterns
●
A meticulous analysis of the competitive landscape, vendor
scorecard, and Porter’s Five Forces
● A wide-ranging study of factors that will challenge the APAC
medical collagen market’s growth during the upcoming years
Want to get specific insights? Our team of
analysts can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
MEDICAL COLLAGEN MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE MEDICAL COLLAGEN INDUSTRY
2.2. KEY
INSIGHTS
2.2.1. SIGNIFICANT
INVESTMENT IN RESEARCH AND DEVELOPMENT ACTIVITIES
2.2.2. EVOLVING
HEALTHCARE INDUSTRY
2.2.3. LAUNCH
OF NEW PRODUCTS DUE TO INCREASED RESEARCH
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
IMPACT ANALYSIS
2.4.1. QUALITY
2.4.2. SIDE-EFFECTS
2.4.3. PRODUCT
EFFECTIVENESS
2.4.4. PRICE
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.8. REGULATORY
FRAMEWORK
2.9. KEY
MARKET STRATEGIES
2.9.1. ACQUISITIONS
2.9.2. PRODUCT
LAUNCHES
2.9.3. PARTNERSHIPS
2.9.4. BUSINESS
EXPANSIONS
2.10. MARKET
DRIVERS
2.10.1. INCREASING
DEMAND FROM THE MEDICAL DEVICES INDUSTRY
2.10.2. GROWING
PUBLIC AWARENESS
2.11. MARKET
CHALLENGES
2.11.1. HEALTH-RELATED
ISSUES
2.11.2. CONSUMERS
LIMITING THE USE OF ANIMAL-BASED PRODUCTS
2.12. MARKET
OPPORTUNITIES
2.12.1. GROWTH
OF THE COSMETICS INDUSTRY
2.12.2. RISING
DEMAND FOR COLLAGEN-RICH FOOD & BEVERAGES
3. ASIA-PACIFIC
MEDICAL COLLAGEN MARKET OUTLOOK – BY SOURCE
3.1. BOVINE
3.2. PORCINE
3.3. OTHER
SOURCES
4. ASIA-PACIFIC
MEDICAL COLLAGEN MARKET OUTLOOK – BY PRODUCT
4.1. GELATINE
4.2. HYDROLYZED
COLLAGEN
4.3. NATIVE
COLLAGEN
4.4. OTHER
PRODUCTS
5. ASIA-PACIFIC
MEDICAL COLLAGEN MARKET OUTLOOK – BY APPLICATION
5.1. WOUND
CARE
5.2. BONE
GRAFTS
5.3. TISSUE
SCAFFOLDS
5.4. CARTILAGE
REPAIR
5.5. HEMOSTATS
5.6. DIAGNOSTICS
5.7. VASCULAR
GRAFTS
5.8. OTHER
APPLICATIONS
6. ASIA-PACIFIC
MEDICAL COLLAGEN MARKET – COUNTRY OUTLOOK
6.1. CHINA
6.2. JAPAN
6.3. INDIA
6.4. SOUTH
KOREA
6.5. ASEAN
COUNTRIES
6.6. AUSTRALIA
& NEW ZEALAND
6.7. REST
OF ASIA-PACIFIC
7. COMPETITIVE
LANDSCAPE
7.1. GELITA
7.2. NITTA
GELATIN INC
7.3. NIPPI
INC
7.4. ITALGEL
7.5. WEISHARDT
7.6. DARLING
INGREDIENTS INC
7.7. LAPI
GELATINE
7.8. TESSENDERLO
GROUP
7.9. DSM
7.10. COLLAGEN
MATRIX INC
7.11. CONNOILS
LLC
7.12. INTEGRA
LIFE SCIENCES
7.13. SYMATESE
7.14. STRYKER
7.15. JELLAGEN
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR
SCORECARD
TABLE 3: REGULATORY
FRAMEWORK
TABLE 4: LIST OF
ACQUISITIONS
TABLE 5: LIST OF
PRODUCT LAUNCHES
TABLE 6: LIST OF
PARTNERSHIPS
TABLE 7: LIST OF
BUSINESS EXPANSIONS
TABLE 8: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY SOURCE, 2022-2028 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY PRODUCT, 2022-2028 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
FIGURE 1: KEY BUYING
IMPACT ANALYSIS
FIGURE 2: MARKET
ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY
COMPONENTS
FIGURE 4: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY SOURCE, 2021 & 2028 (IN %)
FIGURE 5: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY BOVINE, 2022-2028 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY PORCINE, 2022-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY OTHER SOURCES, 2022-2028 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY PRODUCT, 2021 & 2028 (IN %)
FIGURE 9: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY GELATINE, 2022-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY HYDROLYZED COLLAGEN, 2022-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY NATIVE COLLAGEN, 2022-2028 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY OTHER PRODUCTS, 2022-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE 14: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY WOUND CARE, 2022-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY BONE GRAFTS, 2022-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY TISSUE SCAFFOLDS, 2022-2028 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY CARTILAGE REPAIR, 2022-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY HAMOSTATS, 2022-2028 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY DIAGNOSTICS, 2022-2028 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY VASCULAR GRAFTS, 2022-2028 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC
MEDICAL COLLAGEN MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 23: CHINA
MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: JAPAN
MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: INDIA
MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)
FIGURE 26: SOUTH KOREA
MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)
FIGURE 27: ASEAN
COUNTRIES MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)
FIGURE 28: AUSTRALIA
& NEW ZEALAND MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)
FIGURE 29: REST OF
ASIA-PACIFIC MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)